Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008

A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%). Study objectives are to describe clinical manifestations and case management for 26 hospitalised laboratory-confirmed EHF patients. Clinical findings are congruous with previously reported EHF infections. The most frequently experienced symptoms were non-bloody diarrhoea (81%), severe headache (81%), and asthenia (77%). Seven patients reported or were observed with haemorrhagic symptoms, six of whom died. Ebola care remains difficult due to the resource-poor setting of outbreaks and the infection-control procedures required. However, quality data collection is essential to evaluate case definitions and therapeutic interventions, and needs improvement in future epidemics. Organizations usually involved in EHF case management have a particular responsibility in this respect

Optimized intermolecular potential for nitriles based on Anisotropic United Atoms model

An extension of the Anisotropic United Atoms intermolecular potential model is proposed for nitriles. The electrostatic part of the intermolecular potential is calculated using atomic charges obtained by a simple Mulliken population analysis. The repulsion-dispersion interaction parameters for methyl and methylene groups are taken from transferable AUA4 literature parameters [Ungerer et al., J. Chem. Phys., 2000, 112, 5499]. Non-bonding Lennard-Jones intermolecular potential parameters are regressed for the carbon and nitrogen atoms of the nitrile group (–C≡N) from experimental vapor-liquid equilibrium data of acetonitrile. Gibbs Ensemble Monte Carlo simulations and experimental data agreement is very good for acetonitrile, and better than previous molecular potential proposed by Hloucha et al. [J. Chem. Phys., 2000, 113, 5401]. The transferability of the resulting potential is then successfully tested, without any further readjustment, to predict vapor-liquid phase equilibrium of propionitrile and n-butyronitrile

Density of state method for complex action systems

While importance sampling Monte Carlo algorithms have proved to be a crucial tool for numerical studies in modern physics, they fail when we consider complex action systems. The density of states approach provides a way to simulate such systems and reduce the sign problem that afflicts them to a 1-dimensional oscillatory integral. In this work, we shall review the density of states approach as well as the Linear Logarithmic Relaxation algorithm and present some recent development concerning the control of systematics in this algorithm. The results of a benchmark study on the relativistic Bose gas shall be presented as well

The density of states approach to the sign problem

1 + 11 pages, 6 figures. Invited talk presented by B. Lucini at the conference "XIIIth Quark Confinement and the Hadron Spectrum", Maynooth University, Ireland, 1-6 August 2018Approaches to the sign problem based on the density of states have been recently revived by the introduction of the LLR algorithm, which allows us to compute the density of states itself with exponential error reduction. In this work, after a review of the generalities of the method, we show recent results for the Bose gas in four dimensions, focussing on the identification of possible systematic errors and on methods of controlling the bias they can introduce in the calculation

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

BACKGROUND Ustekinumab, a monoclonal antibody to the p40 subunit of interleukin-12 and inter-leukin-23, was evaluated as an intravenous induction therapy in two populations with moderately to severely active Crohn’s disease. Ustekinumab was also evaluated as subcutaneous maintenance therapy. METHODS We randomly assigned patients to receive a single intravenous dose of ustekinumab (either 130 mg or approximately 6 mg per kilogram of body weight) or placebo in two induction trials. The UNITI-1 trial included 741 patients who met the criteria for primary or secondary nonresponse to tumor necrosis factor (TNF) antagonists or had unacceptable side effects. The UNITI-2 trial included 628 patients in whom conventional therapy failed or unacceptable side effects occurred. Patients who completed these induction trials then participated in IM-UNITI, in which the 397 patients who had a response to ustekinumab were randomly assigned to receive subcutaneous maintenance injections of 90 mg of ustekinumab (either every 8 weeks or every 12 weeks) or placebo. The primary end point for the induction trials was a clinical response at week 6 (defined as a decrease from baseline in the Crohn’s Disease Activity Index [CDAI] score of ≥100 points or a CDAI score <150). The primary end point for the maintenance trial was remission at week 44 (CDAI score <150). RESULTS The rates of response at week 6 among patients receiving intravenous ustekinumab at a dose of either 130 mg or approximately 6 mg per kilogram were significantly higher than the rates among patients receiving placebo (in UNITI-1, 34.3%, 33.7%, and 21.5%, respectively, with P≤0.003 for both comparisons with placebo; in UNITI-2, 51.7%, 55.5%, and 28.7%, respectively, with P<0.001 for both doses). In the groups receiving maintenance doses of ustekinumab every 8 weeks or every 12 weeks, 53.1% and 48.8%, respectively, were in remission at week 44, as compared with 35.9% of those receiving placebo (P = 0.005 and P = 0.04, respectively). Within each trial, adverse-event rates were similar among treatment groups. CONCLUSIONS Among patients with moderately to severely active Crohn’s disease, those receiving intravenous ustekinumab had a significantly higher rate of response than did those receiving placebo. Subcutaneous ustekinumab maintained remission in patients who had a clinical response to induction therapy. (Funded by Janssen Research and Development; ClinicalTrials.gov numbers, NCT01369329, NCT01369342, and NCT01369355.

Malaria is an uncommon cause of adult sepsis in south-western Uganda

Malaria is often considered a cause of adult sepsis in malaria endemic areas. However, diagnostic limitations can make distinction between malaria and other infections challenging. Therefore, the objective of this study was to determine the relative contribution of malaria to adult sepsis in south-western Uganda

Efficient computations of continuous action densities of states for lattice models

Abstract The Logarithmic Linear Relaxation (LLR) algorithm is an efficient method for computing densities of states for systems with a continuous spectrum. A key feature of this method is exponential error reduction, which allows us to evaluate the density of states of a system over hundreds of thousands of orders of magnitude with a fixed level of relative accuracy. As a consequence of exponential error reduction, the LLR method provides a robust alternative to traditional Monte Carlo calculations in cases in which states suppressed by the Boltzmann weight play nevertheless a relevant role, e.g., as transition regions between dominant configuration sets. After reviewing the algorithm, we will show an application in U(1) Lattice Gauge Theory that has enabled us to obtain the most accurate estimate of the critical coupling with modest computational resources, defeating exponential tunneling times between metastable vacua. As a further showcase, we will then present an application of the LLR method to the decorrelation of the topological charge in SU(3) Lattice Gauge Theory near the continuum limit. Finally, we will review in general applications of the LLR algorithm to systems affected by a strong sign problem and discuss the case of the Bose gas at finite chemical potential.</jats:p

Quantification of epicardial adipose tissue in obese patients using an open-bore MR scanner

Background Our aim was to evaluate the reproducibility of epicardial adipose tissue (EAT) volume, measured on scans performed using an open-bore magnetic resonance scanner. Methods Consecutive patients referred for bariatric surgery, aged between 18 and 65 years who agreed to undergo cardiac imaging (MRI), were prospectively enrolled. All those with cardiac pathology or contraindications to MRI were excluded. MRI was performed on a 1.0-T open-bore scanner, and EAT was segmented on all scans at both systolic and diastolic phase by two independent readers (R1 with four years of experience and R2 with one year). Data were reported as median and interquartile range; agreement and differences were appraised with Bland-Altman analyses and Wilcoxon tests, respectively. Results Fourteen patients, 11 females (79%) aged 44 (41-50) years, underwent cardiac MRI. For the first and second readings, respectively, EAT volume was 86 (78-95) cm(3) and 85 (79-91) cm(3) at systole and 82 (74-95) cm(3) and 81 (75-94) cm(3) at diastole for R1, and 89 (79-99) cm(3) and 93 (84-98) cm(3) at systole and 92 (85-103) cm(3) and 93 (82-94) cm(3) at diastole for R2. R1 had the best reproducibility at diastole (bias 0.3 cm(3), standard deviation of the differences (SD) 3.3 cm(3)). R2 had the worst reproducibility at diastole (bias 3.9 cm(3), SD 12.1 cm(3)). The only significant difference between systole and diastole was at the first reading by R1 (p = 0.016). The greatest bias was that of inter-reader reproducibility at diastole (-9.4 cm(3)). Conclusions Reproducibility was within clinically acceptable limits in most instances